These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 35662192)

  • 1. Advantages of Rho-associated kinases and their inhibitor fasudil for the treatment of neurodegenerative diseases.
    Wang Q; Song LJ; Ding ZB; Chai Z; Yu JZ; Xiao BG; Ma CG
    Neural Regen Res; 2022 Dec; 17(12):2623-2631. PubMed ID: 35662192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potentials of the Rho kinase inhibitor Fasudil in experimental autoimmune encephalomyelitis and the related mechanisms.
    Yan Y; Yu J; Gao Y; Kumar G; Guo M; Zhao Y; Fang Q; Zhang H; Yu J; Jiang Y; Zhang HT; Ma CG
    Metab Brain Dis; 2019 Apr; 34(2):377-384. PubMed ID: 30552558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodegenerative Disease Associated Pathways in the Brains of Triple Transgenic Alzheimer's Model Mice Are Reversed Following Two Weeks of Peripheral Administration of Fasudil.
    Killick R; Elliott C; Ribe E; Broadstock M; Ballard C; Aarsland D; Williams G
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis.
    Takata M; Tanaka H; Kimura M; Nagahara Y; Tanaka K; Kawasaki K; Seto M; Tsuruma K; Shimazawa M; Hara H
    Br J Pharmacol; 2013 Sep; 170(2):341-51. PubMed ID: 23763343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and Molecular Mechanisms Underly the Combined Treatment of Fasudil and Bone Marrow Derived-Neuronal Stem Cells in a Parkinson's Disease Mouse Model.
    Yan YC; Li YH; Xiao BG; Wang J; Xi JY; Yu WB
    Mol Neurobiol; 2023 Apr; 60(4):1826-1835. PubMed ID: 36580198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Fasudil on remyelination following cuprizone-induced demyelination.
    Wang J; Sui RX; Miao Q; Wang Q; Song LJ; Yu JZ; Li YH; Xiao BG; Ma CG
    CNS Neurosci Ther; 2020 Jan; 26(1):76-89. PubMed ID: 31124292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasudil enhances the phagocytosis of myelin debris and the expression of neurotrophic factors in cuprizone-induced demyelinating mice.
    Ding ZB; Han QX; Wang Q; Song LJ; Chu GG; Guo MF; Chai Z; Yu JZ; Xiao BG; Li XY; Ma CG
    Neurosci Lett; 2021 May; 753():135880. PubMed ID: 33838256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasudil Enhances Therapeutic Efficacy of Neural Stem Cells in the Mouse Model of MPTP-Induced Parkinson's Disease.
    Li YH; Yu JW; Xi JY; Yu WB; Liu JC; Wang Q; Song LJ; Feng L; Yan YP; Zhang GX; Xiao BG; Ma CG
    Mol Neurobiol; 2017 Sep; 54(7):5400-5413. PubMed ID: 27590141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the ROCK inhibitor fasudil on the brain proteomic profile in the tau transgenic mouse model of Alzheimer's disease.
    Collu R; Yin Z; Giunti E; Daley S; Chen M; Morin P; Killick R; Wong STC; Xia W
    Front Aging Neurosci; 2024; 16():1323563. PubMed ID: 38440100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rho kinase inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosis.
    Tönges L; Günther R; Suhr M; Jansen J; Balck A; Saal KA; Barski E; Nientied T; Götz AA; Koch JC; Mueller BK; Weishaupt JH; Sereda MW; Hanisch UK; Bähr M; Lingor P
    Glia; 2014 Feb; 62(2):217-32. PubMed ID: 24311453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Rho kinase inhibitor fasudil attenuates Aβ
    Gao Y; Yan Y; Fang Q; Zhang N; Kumar G; Zhang J; Song LJ; Yu J; Zhao L; Zhang HT; Ma CG
    Metab Brain Dis; 2019 Dec; 34(6):1787-1801. PubMed ID: 31482248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Rho-associated kinase inhibitor fasudil hydrochloride enhances neural regeneration after axotomy in the peripheral nervous system.
    Madura T; Kubo T; Tanag M; Matsuda K; Tomita K; Yano K; Hosokawa K
    Plast Reconstr Surg; 2007 Feb; 119(2):526-35. PubMed ID: 17230085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho kinase inhibitor fasudil protects against β-amyloid-induced hippocampal neurodegeneration in rats.
    Song Y; Chen X; Wang LY; Gao W; Zhu MJ
    CNS Neurosci Ther; 2013 Aug; 19(8):603-10. PubMed ID: 23638992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of experimental autoimmune encephalomyelitis by Fasudil, a Rho kinase inhibitor.
    Yu JZ; Ding J; Ma CG; Sun CH; Sun YF; Lu CZ; Xiao BG
    J Neurosci Res; 2010 Jun; 88(8):1664-72. PubMed ID: 20077431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rho kinase inhibitor fasudil reduces l-DOPA-induced dyskinesia in a rat model of Parkinson's disease.
    Lopez-Lopez A; Labandeira CM; Labandeira-Garcia JL; Muñoz A
    Br J Pharmacol; 2020 Dec; 177(24):5622-5641. PubMed ID: 32986850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models.
    Ying H; Biroc SL; Li WW; Alicke B; Xuan JA; Pagila R; Ohashi Y; Okada T; Kamata Y; Dinter H
    Mol Cancer Ther; 2006 Sep; 5(9):2158-64. PubMed ID: 16985048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Rho-kinase by Fasudil protects dopamine neurons and attenuates inflammatory response in an intranasal lipopolysaccharide-mediated Parkinson's model.
    He Q; Li YH; Guo SS; Wang Y; Lin W; Zhang Q; Wang J; Ma CG; Xiao BG
    Eur J Neurosci; 2016 Jan; 43(1):41-52. PubMed ID: 26565388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibition of Rho kinase blocks cell migration and accumulation possibly by challenging inflammatory cytokines and chemokines on astrocytes.
    Guo MF; Meng J; Li YH; Yu JZ; Liu CY; Feng L; Yang WF; Li JL; Feng QJ; Xiao BG; Ma CG
    J Neurol Sci; 2014 Aug; 343(1-2):69-75. PubMed ID: 24952673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasudil, a Rho kinase inhibitor, drives mobilization of adult neural stem cells after hypoxia/reoxygenation injury in mice.
    Ding J; Li QY; Yu JZ; Wang X; Sun CH; Lu CZ; Xiao BG
    Mol Cell Neurosci; 2010 Feb; 43(2):201-8. PubMed ID: 19913617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ROCKs as therapeutic targets in cardiovascular diseases.
    Rikitake Y; Liao JK
    Expert Rev Cardiovasc Ther; 2005 May; 3(3):441-51. PubMed ID: 15889972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.